| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |